Colonial Trust Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.33K Hold
1,100
﹤0.01% 591
2026
Q1
$6K Hold
1,100
﹤0.01% 586
2025
Q4
$7.7K Hold
1,100
﹤0.01% 544
2025
Q3
$8.5K Hold
1,100
﹤0.01% 515
2025
Q2
$9.58K Hold
1,100
﹤0.01% 515
2025
Q1
$8.76K Buy
1,100
+200
+22% +$2.02K ﹤0.01% 511
2024
Q4
$8.18K Buy
900
+500
+125% +$4.83K ﹤0.01% 508
2024
Q3
$3.67K Hold
400
﹤0.01% 645
2024
Q2
$3.91K Hold
400
﹤0.01% 634
2024
Q1
$6.04K Hold
400
﹤0.01% 673
2023
Q4
$8.62K Hold
400
﹤0.01% 523
2023
Q3
$7.44K Hold
400
﹤0.01% 554
2023
Q2
$10.1K Buy
400
+100
+33% +$2.52K ﹤0.01% 523
2023
Q1
$7.77K Buy
300
+100
+50% +$2.68K ﹤0.01% 557
2022
Q4
$4.73K Buy
+200
New +$5.39K ﹤0.01% 627

Other funds holding TDOC

Colonial Trust Advisors's TDOC Position: Q2 2026 in Review

Colonial Trust Advisors held its Teladoc Health (TDOC) position steady in Q2 2026 at 1,100 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Colonial Trust Advisors first reported a position in TDOC in Q4 2022 and has held it in 15 quarters since. The position peaked at $10.1K in Q2 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Colonial Trust Advisors held 1,100 shares of Teladoc Health worth $9.33K as of Q2 2026.
  • Colonial Trust Advisors left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #591 holding.
  • Colonial Trust Advisors first reported a position in Teladoc Health in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust Advisors's Teladoc Health position peaked at $10.1K in Q2 2023.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.